Back to search

Article

A gene signature predicting prognosis of patients with low- grade gliomas receiving temozolomide therapy

2023-04-19

Abstract excerpt

Temozolomide (TMZ) has been used as a first-line therapy against low-grade gliomas (LGGs) combined with other chemotherapy drugs. However, there has been no reliable index predicting TMZ response of patients with LGGs. In this study, we aim to investigate the relationship between gene expressions and the prognosis of TMZ therapy in LGGs. We integrated transcriptome and clinical data of 171 LGGs from the Chinese Gl...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
309c35bf-0db4-56ba-bf4e-2a12ba27b3d7
DOI
10.21203/rs.3.rs-2822634/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A gene signature predicting prognosis of patients with low- grade gliomas receiving temozolomide therapyDOI 10.21203/rs.3.rs-2822634/v1
Select a neighboring publication to make it the new centre.